Insulinoma risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
(Mahshid) |
||
| (7 intermediate revisions by one other user not shown) | |||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
Common risk factors in the development of insulinoma include female gender, age | Common risk factors in the development of insulinoma include female gender, age group 40-60 years, [[Multiple endocrine neoplasia type 1|MEN1]] syndrome, [[Von Hippel-Lindau Disease|Von Hippel-Lindau]] disease, and [[Neurofibromatosis type I|neurofibromatosis 1]]. | ||
==Risk Factors== | ==Risk Factors== | ||
===Common Risk Factors=== | ===Common Risk Factors=== | ||
Common [[risk factors]] in the development of insulinoma include: | |||
** | *Gender | ||
**[[Females]] are more at risk of developing insulinoma than [[males]]. | |||
*[[Age]] | |||
**People who are in the age range of 40-60 years. | |||
*[[Genetics]] | |||
**Persons with [[family history]] of [[pancreatic neuroendocrine tumor]]<nowiki/>s are at higher risk of developing insulinomas. <ref name="pmid23742779">{{cite journal| author=Zhan HX, Cong L, Zhao YP, Zhang TP, Chen G| title=Risk factors for the occurrence of insulinoma: a case-control study. | journal=Hepatobiliary Pancreat Dis Int | year= 2013 | volume= 12 | issue= 3 | pages= 324-8 | pmid=23742779 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23742779 }} </ref> | |||
**People with associated [[Multiple endocrine neoplasia type 1]] syndrome ([[Multiple endocrine neoplasia type 1|MEN 1]]).<ref name="pmid23742779">{{cite journal |vauthors=Zhan HX, Cong L, Zhao YP, Zhang TP, Chen G |title=Risk factors for the occurrence of insulinoma: a case-control study |journal=HBPD INT |volume=12 |issue=3 |pages=324–8 |year=2013 |pmid=23742779 |doi= |url=}}</ref><ref name="pmid1677058">{{cite journal| author=Service FJ, McMahon MM, O'Brien PC, Ballard DJ| title=Functioning insulinoma--incidence, recurrence, and long-term survival of patients: a 60-year study. | journal=Mayo Clin Proc | year= 1991 | volume= 66 | issue= 7 | pages= 711-9 | pmid=1677058 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1677058 }} </ref><ref name="pmid9735690">{{cite journal| author=Boukhman MP, Karam JH, Shaver J, Siperstein AE, Duh QY, Clark OH| title=Insulinoma--experience from 1950 to 1995. | journal=West J Med | year= 1998 | volume= 169 | issue= 2 | pages= 98-104 | pmid=9735690 | doi= | pmc=1305178 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9735690 }} </ref><ref name="urlInsulinoma - Health Encyclopedia - University of Rochester Medical Center">{{cite web |url=https://www.urmc.rochester.edu/encyclopedia/content.aspx?contenttypeid=134&contentid=219 |title=Insulinoma - Health Encyclopedia - University of Rochester Medical Center |format= |work= |accessdate=}}</ref> | |||
===Less Common Risk Factors=== | ===Less Common Risk Factors=== | ||
Less common [[risk factors]] in the development of insulinoma include: | |||
*[[Von Hippel-Lindau Disease|Von Hippel-Lindau]] disease | |||
*[[Neurofibromatosis type I|Neurofibromatosis]] type 1 <ref name="pmid23742779">{{cite journal |vauthors=Zhan HX, Cong L, Zhao YP, Zhang TP, Chen G |title=Risk factors for the occurrence of insulinoma: a case-control study |journal=HBPD INT |volume=12 |issue=3 |pages=324–8 |year=2013 |pmid=23742779 |doi= |url=}}</ref><ref name="urlInsulinoma - Health Encyclopedia - University of Rochester Medical Center">{{cite web |url=https://www.urmc.rochester.edu/encyclopedia/content.aspx?contenttypeid=134&contentid=219 |title=Insulinoma - Health Encyclopedia - University of Rochester Medical Center |format= |work= |accessdate=}}</ref> | |||
==References== | ==References== | ||
| Line 26: | Line 29: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Medicine]] | |||
[[Category:Endocrinology]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Gastroenterology]] | |||
[[Category:Surgery]] | |||
Latest revision as of 02:07, 27 November 2017
|
Insulinoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Insulinoma risk factors On the Web |
|
American Roentgen Ray Society Images of Insulinoma risk factors |
|
Risk calculators and risk factors for Insulinoma risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]
Overview
Common risk factors in the development of insulinoma include female gender, age group 40-60 years, MEN1 syndrome, Von Hippel-Lindau disease, and neurofibromatosis 1.
Risk Factors
Common Risk Factors
Common risk factors in the development of insulinoma include:
- Gender
- Age
- People who are in the age range of 40-60 years.
- Genetics
- Persons with family history of pancreatic neuroendocrine tumors are at higher risk of developing insulinomas. [1]
- People with associated Multiple endocrine neoplasia type 1 syndrome (MEN 1).[1][2][3][4]
Less Common Risk Factors
Less common risk factors in the development of insulinoma include:
- Von Hippel-Lindau disease
- Neurofibromatosis type 1 [1][4]
References
- ↑ 1.0 1.1 1.2 Zhan HX, Cong L, Zhao YP, Zhang TP, Chen G (2013). "Risk factors for the occurrence of insulinoma: a case-control study". Hepatobiliary Pancreat Dis Int. 12 (3): 324–8. PMID 23742779.
- ↑ Service FJ, McMahon MM, O'Brien PC, Ballard DJ (1991). "Functioning insulinoma--incidence, recurrence, and long-term survival of patients: a 60-year study". Mayo Clin Proc. 66 (7): 711–9. PMID 1677058.
- ↑ Boukhman MP, Karam JH, Shaver J, Siperstein AE, Duh QY, Clark OH (1998). "Insulinoma--experience from 1950 to 1995". West J Med. 169 (2): 98–104. PMC 1305178. PMID 9735690.
- ↑ 4.0 4.1 "Insulinoma - Health Encyclopedia - University of Rochester Medical Center".